Using dual-wavelength spectrometry, we have refined the mordant-based bilirubin slide method (Clin Chem 28:2366-2372, 1982) to co-detect unconjugated bilirubin (Bu) and its sugar conjugates (Bc) in 10 microL of serum. The assay is based on three principles: (a) mono- and diconjugated bilirubins behave spectrally like one fraction (Bc) when bound to the mordant, (b) Bu and Bc are spectrally distinct, and (c) B delta (the bilirubin-albumin complex) is not measured in the film. With known bilirubin mixtures, results by the assay agree with those by nuclear magnetic resonance, by a Jendrassik-Gróf method for total bilirubin, and by a liquid-chromatographic procedure. With patients' sera, the slide correlates with a liquid-chromatography-augmented Jendrassik-Gróf method, according to the following typical regression statistics (in mumol/L): for Bu, slope = 0.992, r = 0.996, intercept = -0.376, Sy X x = 5.08; for Bc, slope = 0.970, r = 0.985, intercept = -0.735, Sy X x = 8.16. The method is precise (for Bu, CV = 5.2% at an average concentration of 16.4 mumol/L, and 4.1% at 66.7 mumol/L; for Bc, CV = 6.5% at 23.4 mumol/L, and 3.8% at 151.7 mumol/L for pools of patients' sera), is relatively interference free, and has potential for extension to further applications.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!